Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Europe COVID-19 Diagnostics Market: By Test Type: PCR Test, Antigen Test, Antibody Test, Others; By Product: RT-PCR Assay Kits, Immunoassay Test Strips, Others; By Sample Type; By Business Model; By End Use: Hospitals, Diagnostic Centres and Clinics, Laboratories, Others; By Country (2020-2026); Competitive Landscape, 2021-2026

Europe COVID-19 Diagnostics Market Outlook

The Europe COVID-19 diagnostics market is being aided by the growing cases of COVID-19 infections in the UK and France, which have performed around 112 million and 58 million tests, respectively, for COVID-19 as of March 2021.

 

Favourable Government Policies to Aid the Market Growth of COVID-19 Diagnostics

The rising cases of COVID-19 have boosted the funding from government and private institutions for R&D in the field. Further, the rising number of emergency use authorizations for diagnostic kits & products, and advances and sponsorship from non-medical device or diagnostic firms have been projected to affect the global COVID-19 diagnostics industry positively. Many of the leading manufacturers of COVID-19 diagnostics are from European countries such as Germany and Italy. The development of various effective tests is expected to help the market growth over the coming years.

 

COVID-19 Diagnostics: Industry Definition and Segmentation

COVID-19 diagnostics are standardized equipment used for the detection and diagnosis of Covid-19. These are manufactured by approved pharmaceutical manufacturers under strict government procedures.

By test type, the market is divided into:

  • PCR Test
  • Antigen Test
  • Antibody Test
  • Others

The market is categorised in terms of product into:

  • RT-PCR Assay Kits
  • Immunoassay Test Strips
  • Others

The market is divided on the basis of sample type into:

  • Nasopharyngeal Swab
  • Oropharyngeal (OP) Swab
  • Nasal Swab
  • Blood Test
  • Others

On the basis of business mode, the industry is bifurcated into:

  • Point-of-Care (PoC) Testing 
  • Non-Point-of-Care (PoC) Testing

In terms of end use, the market is segmented into:

  • Hospitals
  • Diagnostic Centres and Clinics
  • Laboratories
  • Others

The EMR report looks into the regional markets of the product like Germany, Italy, the UK, France, and rest of Europe.

 

Rise in Government Funding to Boost the Market Growth of COVID-19 Diagnostics in Europe

Increased government spending and a rising range of strategic partnerships drive the industry for COVID-19 diagnostics in Europe. Furthermore, increased federal spending is expected to fuel business demand, consequently aiding the market growth. In the forecast period, molecular (PCR) testing is expected to lead the industry. The PCR technique is actually believed to be the most effective for detecting COVID-19, resulting in a significant rise in the use of PCR research kits. This is well supported by governments across Europe which are also preparing for a mass vaccination campaign. The laboratories section is projected to produce the greatest demand.

However, due to the already in place vaccination drive started in countries such as UK, the market for COVID-19 diagnostics is also expected to witness a steep decline in the forecast period, which shall be the overriding market trend for this industry. The sharp decline is expected to end in a near fade-out of this market by the end of the forecast period due to vaccination of the global population.

 

Key Industry Players in the Europe COVID-19 Diagnostics Market

The report gives a detailed analysis of the following key players in the Europe COVID-19 diagnostics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Altona Diagnostics GmbH
  • Genomica S.A.U
  • Clonit srl
  • BioMaxima SA
  • Primerdesign Ltd
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Europe
7    Industry Opportunities and Challenges
8    Europe COVID-19 Overview

    8.1    Number of COVID-19 Cases in Europe
    8.2    Europe COVID-19 Cases by Country
        8.2.1    United Kingdom
        8.2.2    Germany
        8.2.3    Italy
        8.2.4    France
        8.2.5    Spain
        8.2.6    Others
9    Europe COVID-19 Diagnostics Market Analysis
    9.1    Key Industry Highlights
    9.2    Europe COVID-19 Diagnostics Market (2020-2026)
    9.3    Europe COVID-19 Diagnostics Market by Test Type (2020-2026)
        9.3.1    PCR Test 
        9.3.2    Antigen Test
        9.3.3    Antibody Test
        9.3.4    Others
    9.4    Europe COVID-19 Diagnostics Market by Product (2020-2026)
        9.4.1    RT-PCR Assay Kits
        9.4.2    Immunoassay Test Strips
        9.4.3    Others
    9.5    Europe COVID-19 Diagnostics Market by Sample Type (2020-2026) 
        9.5.1    Nasopharyngeal Swab
        9.5.2    Oropharyngeal (OP) Swab
        9.5.3    Nasal Swab
        9.5.4    Blood Test
        9.5.5    Others
    9.6    Europe COVID-19 Diagnostics Market by Business Mode (2020-2026)
        9.6.1    Point-of-Care (PoC) Testing
        9.6.2    Non-Point-of-Care (PoC) Testing
    9.7    Europe COVID-19 Diagnostics Market by End Use (2020-2026)
        9.7.1    Hospitals 
        9.7.2    Diagnostic Centres and Clinics   
        9.7.3    Laboratories
        9.7.4    Others
    9.8    Europe COVID-19 Diagnostics Market by Country (2020-2026)
        9.8.1    United Kingdom
        9.8.2    Germany
        9.8.3    Italy
        9.8.4    France
        9.8.5    Spain
        9.8.6    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Altona Diagnostics GmbH
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Genomica S.A.U
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Clonit srl
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    BioMaxima SA
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Primerdesign Ltd 
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Others
13    Industry Events and Developments


List of Figures and Tables

1.    Europe COVID-19 Cases by Country
2.    Europe COVID-19 Diagnostics Market: Key Industry Highlights, 2020 and 2026
3.    Europe COVID-19 Diagnostics Market: Breakup by Test Type (USD Billion)
4.    Europe COVID-19 Diagnostics Market: Breakup by Product (USD Billion)
5.    Europe COVID-19 Diagnostics Market: Breakup by Sample Type (USD Billion)
6.    Europe COVID-19 Diagnostics Market: Breakup by Business Model (USD Billion)
7.    Europe COVID-19 Diagnostics Market: Breakup by End Use (USD Billion)
8.    Europe COVID-19 Diagnostics Market: Breakup by Country (USD Billion), 
9.    Europe COVID-19 Diagnostics Market Structure

Key Questions Answered in the Report

The Europe COVID-19 diagnostics market is being aided by the growing cases of COVID-19 infections in the UK and France, which have performed around 112 million and 58 million tests, respectively, for COVID-19 as of March 2021.

The major drivers of the industry such as rising research and development, rising cases of COVID-19, and favourable government policies, are aiding the market growth.

The key market trend guiding the growth of the industry includes the technological advancements.

The major regions in the industry are Germany, Italy, the UK, France, and rest of Europe.

The major test types available in the industry are PCR test, antigen test, and antibody test, among others.

The major products available in the industry are RT-PCR assay kits, and immunoassay test strips, among others.

The sample types available in the market are nasopharyngeal swab, oropharyngeal (OP) swab, nasal swab, and blood test, among others.

The significant business modes are point-of-care (PoC) testing and non-point-of-care (PoC) testing.

The significant end use sectors are hospitals, diagnostic centres and clinics, and laboratories, among others.

The major players in the industry are Altona Diagnostics GmbH, Genomica S.A.U, Clonit srl, BioMaxima SA, and Primerdesign Ltd, among others.

Analyst Review

The Europe COVID-19 diagnostics market is being aided by the growing cases of COVID-19 infections in the UK and France, which have performed around 112 million and 58 million tests, respectively, for COVID-19 as of March 2021. The market is aided by favourable government policies and rise in funding for R&D in this field.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its test types, the COVID-19 diagnostics industry can be segmented into PCR test, antigen test, and antibody test, among others. On the basis of products, the industry is divided into RT-PCR assay kits, and immunoassay test strips, among others. By sample types, the industry is categorised into nasopharyngeal swab, oropharyngeal (OP) swab, nasal swab, and blood test, among others. On the basis of business modes, the industry is segmented into point-of-care (PoC) testing and non-point-of-care (PoC) testing. Based on end use sectors, the industry is segregated into hospitals, diagnostic centres and clinics, and laboratories, among others. The major regional markets for COVID-19 diagnostics in Europe are Germany, Italy, the UK, France, and rest of Europe. The key players in the above market include Altona Diagnostics GmbH, Genomica S.A.U, Clonit srl, BioMaxima SA, and Primerdesign Ltd, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 1999     $1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports

North America COVID-19 Diagnostics Market Report and Forecast 2021-2026


Global COVID-19 Diagnostics Market Report and Forecast 2021-2026


Asia Pacific COVID-19 Diagnostics Market Report and Forecast 2021-2026



Latin America COVID-19 Diagnostics Market Report and Forecast 2021-2026


NEWSLETTER